查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1360308

癌症診斷市場中的人工智慧 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

AI in Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 153 Pages | 商品交期: 2-10個工作天內

價格

癌症診斷市場中的人工智慧 - 報告範圍

TMR 關於全球癌症診斷市場人工智慧的報告研究了過去以及當前的成長趨勢和機會，以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球人工智慧在癌症診斷市場中的營收2017-2031 年癌症診斷市場，以 2023 年為基準年，2031 年為預測年。該報告也提供了2023年至2031年全球人工智慧在癌症診斷市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解癌症診斷市場中的人工智慧。

市場概況
2023年市場價值 8.59 億美元
2031 年市場價值 20 億美元
年複合成長率 11.2%

該報告深入探討了全球人工智慧在癌症診斷市場的競爭格局。全球癌症診斷市場人工智慧的主要參與者已經確定，並且每位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球癌症診斷市場人工智慧參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 腫瘤學中機器學習的不同技術概述
  • 技術進步
  • 用作的主要軟體列表
  • 按地區/全球分類的監管情景
  • COVID-19 大流行對產業的影響（價值鍊和短期/中期/長期影響）

第 6 章：全球市場分析與預測：按組成部分

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按組成部分，2017-2031
    • 軟體解決方案
    • 服務
  • 市場吸引力分析：按組成部分

第 7 章：全球市場分析與預測：按癌症類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按癌症類型，2017-2031
    • 乳癌
    • 攝護腺癌
    • 肺癌
    • 大腸直腸癌
    • 子宮頸癌
    • 其他
  • 市場吸引力分析：按癌症類型

第 8 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 篩檢與診斷
    • 腫瘤識別
    • 監控
  • 市場吸引力分析：按應用

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院
    • 診斷中心
    • 醫學研究機構
    • 合約研究組織
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者-競爭矩陣：依公司層級與規模分類
  • 市佔率分析：依公司分類，2022 年
  • 公司簡介
    • Ibex Medical Analytics
    • EarlySign
    • Cancer Center.ai
    • Microsoft
    • Flatiron
    • Path AI
    • Therapixel
    • Tempus
    • Paige AI, Inc.
    • Kheiron Medical Technologies Limited
    • SkinVision
    • Freenome
    • Whiterabbit.ai
    • Mindpeak GmbH
Product Code: TMRGL85783

AI in Cancer Diagnostics Market - Scope of Report

TMR's report on the global AI in cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global AI in cancer diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global AI in cancer diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the AI in cancer diagnostics market.

Market Snapshot
Market Value in 2023US$ 859 Mn
Market Value in 2031US$ 2 Bn
CAGR11.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global AI in cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in cancer diagnostics market.

The report delves into the competitive landscape of the global AI in cancer diagnostics market. Key players operating in the global AI in cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in cancer diagnostics market profiled in this report.

Key Questions Answered in Global AI in Cancer Diagnostics Market Report:

  • What is the sales/revenue generated by AI in cancer diagnostics across all regions during the forecast period?
  • What are the opportunities in the global AI in cancer diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

AI in Cancer Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global AI in cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in cancer diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global AI in Cancer Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Component Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global AI in Cancer Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Different Technique Overview of Machine Learning in Oncology
  • 5.2. Technological Advancements
  • 5.3. List of Major Software used as AI in Cancer Diagnostics
  • 5.4. Regulatory Scenario by Region/Globally
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Component

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2017-2031
    • 6.3.1. Software Solutions
    • 6.3.2. Services
  • 6.4. Market Attractiveness Analysis, by Component

7. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Cancer Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 7.3.1. Breast Cancer
    • 7.3.2. Prostate Cancer
    • 7.3.3. Lung Cancer
    • 7.3.4. Colorectal Cancer
    • 7.3.5. Cervical Cancer
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Cancer Type

8. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Screening & Diagnosis
    • 8.3.2. Tumor Identification
    • 8.3.3. Monitoring
  • 8.4. Market Attractiveness Analysis, by Application

9. Global AI in Cancer Diagnostics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Medical Research Institutes
    • 9.3.4. Contract Research Organizations
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America AI in Cancer Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Component, 2017-2031
    • 11.2.1. Software Solutions
    • 11.2.2. Services
  • 11.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 11.3.1. Breast Cancer
    • 11.3.2. Prostate Cancer
    • 11.3.3. Lung Cancer
    • 11.3.4. Colorectal Cancer
    • 11.3.5. Cervical Cancer
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Screening & Diagnosis
    • 11.4.2. Tumor Identification
    • 11.4.3. Monitoring
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Medical Research Institutes
    • 11.5.4. Contract Research Organizations
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Component
    • 11.7.2. By Cancer Type
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe AI in Cancer Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Component, 2017-2031
    • 12.2.1. Software Solutions
    • 12.2.2. Services
  • 12.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 12.3.1. Breast Cancer
    • 12.3.2. Prostate Cancer
    • 12.3.3. Lung Cancer
    • 12.3.4. Colorectal Cancer
    • 12.3.5. Cervical Cancer
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Screening & Diagnosis
    • 12.4.2. Tumor Identification
    • 12.4.3. Monitoring
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Medical Research Institutes
    • 12.5.4. Contract Research Organizations
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Component
    • 12.7.2. By Cancer Type
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific AI in Cancer Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Component, 2017-2031
    • 13.2.1. Software Solutions
    • 13.2.2. Services
  • 13.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 13.3.1. Breast Cancer
    • 13.3.2. Prostate Cancer
    • 13.3.3. Lung Cancer
    • 13.3.4. Colorectal Cancer
    • 13.3.5. Cervical Cancer
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Screening & Diagnosis
    • 13.4.2. Tumor Identification
    • 13.4.3. Monitoring
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Medical Research Institutes
    • 13.5.4. Contract Research Organizations
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Component
    • 13.7.2. By Cancer Type
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America AI in Cancer Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Component, 2017-2031
    • 14.2.1. Software Solutions
    • 14.2.2. Services
  • 14.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 14.3.1. Breast Cancer
    • 14.3.2. Prostate Cancer
    • 14.3.3. Lung Cancer
    • 14.3.4. Colorectal Cancer
    • 14.3.5. Cervical Cancer
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Screening & Diagnosis
    • 14.4.2. Tumor Identification
    • 14.4.3. Monitoring
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Medical Research Institutes
    • 14.5.4. Contract Research Organizations
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Component
    • 14.7.2. By Cancer Type
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa AI in Cancer Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Component, 2017-2031
    • 15.2.1. Software Solutions
    • 15.2.2. Services
  • 15.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 15.3.1. Breast Cancer
    • 15.3.2. Prostate Cancer
    • 15.3.3. Lung Cancer
    • 15.3.4. Colorectal Cancer
    • 15.3.5. Cervical Cancer
    • 15.3.6. Others
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Screening & Diagnosis
    • 15.4.2. Tumor Identification
    • 15.4.3. Monitoring
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Centers
    • 15.5.3. Medical Research Institutes
    • 15.5.4. Contract Research Organizations
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Component
    • 15.7.2. By Cancer Type
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix, by tier and size of companies
  • 16.2. Market Share Analysis, by Company, 2022
  • 16.3. Company Profiles
    • 16.3.1. Ibex Medical Analytics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. EarlySign
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Cancer Center.ai
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Microsoft
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Flatiron
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Path AI
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Therapixel
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Tempus
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Paige AI, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Kheiron Medical Technologies Limited
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. SkinVision
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Freenome
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Whiterabbit.ai
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Mindpeak GmbH
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview

List of Tables

  • Table 01: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 02: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 07: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 08: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 12: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 13: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 17: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 18: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 22: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 23: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 27: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 28: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 02: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Software Solutions, 2017-2031
  • Figure 04: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Services, 2017-2031
  • Figure 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Figure 06: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 07: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 08: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
  • Figure 09: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Lung Cancer, 2017-2031
  • Figure 10: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
  • Figure 11: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Cervical Cancer, 2017-2031
  • Figure 12: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 13: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Figure 14: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Application, 2023-2031
  • Figure 15: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Screening & Diagnosis, 2017-2031
  • Figure 16: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Tumor Identification, 2017-2031
  • Figure 17: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Monitoring, 2017-2031
  • Figure 18: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 19: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 20: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 21: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
  • Figure 22: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Medical Research Institutes, 2017-2031
  • Figure 23: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Contract Research Organizations, 2017-2031
  • Figure 24: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Figure 25: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America AI in Cancer Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 28: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 29: North America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 30: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 31: North America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 32: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 33: North America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 34: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: North America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 36: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 37: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 38: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 40: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 41: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 42: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 43: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 44: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 52: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 53: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 54: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 55: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 56: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 57: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 60: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 62: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 63: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 64: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 65: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 66: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 67: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 68: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 69: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 70: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 71: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 72: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 73: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 74: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 75: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 76: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 77: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 78: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Global AI in Cancer Diagnostics Market Share Analysis, by Company 2022